Veronika J. Wirtz, MSc, PhD is a Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy. Her research focuses on health system strengthening and policy and program evaluations of medicines access and utilization. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico.
Her interest and expertise include medicines price analysis, generic medicines policies, quality use of medicines, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.
Between 2014 and 2016 she was the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission had the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission Essential Medicines for Universal Coverage was published in 2016.
From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.
She has worked as a technical adviser for various international organizations, among them the World Health Organization, the Pan American Health Organization, the World Bank, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health. Since Fall 2016 she is Associate Editor of Health Systems & Reform, a leading journal publishing health system and policy research.
She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.
Diversity, Equity, Inclusion and Accessibility
Diversity, Equity, Inclusion and Accessibility (DEIA) are core to my work as a public health researcher, educator and practitioner. According to the BUSPH’s motto Think, Teach, Do, my contribution to DEIA touches all three dimensions:
Think: My research centers on equity, namely increasing equitable access to medicines and health technologies around the globe. For nearly 20 years I have generated knowledge and insights to improve policies that would enhance equity in medicines access.
Teach: Creating a classroom environment that fosters equal learning opportunities for students from different backgrounds and various learning styles and abilities is core to my teaching philosophy. I am attentive to students' needs and I accommodate each and every one accordingly. I create an open learning environment that allows students to contribute in class and outside the classroom. Feedback from my students and teaching assistants over the past 10 years at BUSPH shows this.
Do: I am the co-founder and faculty lead of Emerging Women Leaders, a career mentoring program for doctoral students at BUSPH. The mission of the program is to encourage more women and other groups historically underrepresented in high-level public health positions, including Black, Latinx, disabled and queer, to engage in leadership and to foster inclusive work environments. Since the inception of the program in 2019 over 40 students from all 5 doctoral programs have taken part in the year-long mentor circles and benefitted from the career mentoring and workshop.
Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program
11/05/2018 - 07/13/2023 (Subcontract PI)Management Sciences for Health USAID
Boston University Collaboration with Global Patient Solutions
11/16/2021 - 06/30/2023 (PI)Gilead Sciences, Inc.
Metrics for UCB's new Epilepsy Patients Reacher (EPR) Mumbai Pilot
01/01/2022 - 12/31/2022 (Multi-PI)
PI: Veronika Wirtz, BPharm, MSc, PhDUCB Pharma S.A. Belgium The King Baudouin Fd
Metrics for UCB’s new Epilepsy Patients Reach (EPR) Mumbai Pilot
01/01/2022 - 12/31/2022 (Multi-PI)
PI: Veronika Wirtz, BPharm, MSc, PhDThe King Baudouin Foundation
Medicines price control interventions in Southeast Asia: policy review and recommendations for further research
08/01/2020 - 03/31/2022 (PI)World Health Organization
Amgen Access Metrics (Work Order #1)
05/01/2020 - 12/31/2021 (Multi-PI)
PI: Veronika Wirtz, BPharm, MSc, PhDAmgen, Inc.
Developing a Measurement Framework for Roche Access Programs
04/22/2020 - 12/31/2021 (Multi-PI)
PI: Veronika Wirtz, BPharm, MSc, PhDF. Hoffmann-La Roche, Ltd.
Revision and Update of the WHO Medicines Price Information Repository
05/10/2021 - 11/30/2021 (PI)World Health Organization
Factors influencing the uptake of the tenofovir voluntary licensing program by eligible manufacturers and medicine purchasers in licensed countries
01/01/2019 - 10/31/2021 (PI)Gilead Sciences, Inc.
Evaluation of Novartis Access in Kenya - Scope of Work 6
04/01/2020 - 03/31/2021 (Multi-PI)
PI: Veronika Wirtz, BPharm, MSc, PhDSandoz International GmbH
Showing 10 of 21 results.
Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 163 results.
Vargas López LC, Wirtz VJ, Reich MR. Pharmaceutical services in public hospitals in Mexico: a cross-sectional study. Int J Pharm Pract. 2022 Mar 16. PMID: 35294016
Smith-Sreen J, Heerdegen ACS, Wirtz VJ, Kulkarni P, Machado M, Rockers PC. Commercial and Social Value of Pharmaceutical Industry-led Access Programs: Conceptual Framework and Descriptive Analysis. Health Syst Reform. 2022 Jan 01; 8(1):e2057831.View Related Profiles. PMID: 35583505
Serván-Mori E, Orozco-Núñez E, Heredia-Pi I, Armenta-Paulino N, Wirtz VJ, Meneses-Navarro S, Nigenda G. Public health insurance and ethnic disparities in maternal health care: the case of vulnerable Mexican women over the last 25 years. Health Policy Plan. 2021 Nov 11; 36(10):1671-1680. PMID: 34557904
Wirtz VJ, Servan-Mori E, Mungai J, Mboya J, Rockers PC, Onyango MA, Kiragu ZW, Laing R. Probability and amount of medicines expenditure according to health insurance status in Kenya: A household survey in eight counties. Int J Health Plann Manage. 2022 Mar; 37(2):725-733.View Related Profiles. PMID: 34674309; DOI: 10.1002/hpm.3368;
Aljadeeah S, Nagel E, Wirtz VJ. Outpatient cardiovascular diseases and diabetes medicines dispensing in the population with government health insurance in Syria between 2018 and 2019: a retrospective analysis. BMC Health Serv Res. 2021 Oct 13; 21(1):1088. PMID: 34645430; PMCID: PMC8515648; DOI: 10.1186/s12913-021-07124-6;
Orubu ESF, Samad MA, Rahman MT, Zaman MH, Wirtz VJ. Mapping the Antimicrobial Supply Chain in Bangladesh: A Scoping-Review-Based Ecological Assessment Approach. Glob Health Sci Pract. 2021 09 30; 9(3):532-547. PMID: 34593580; PMCID: PMC8514039; DOI: 10.9745/GHSP-D-20-00502;
Aljadeeah S, Wirtz VJ, Nagel E. Cross-sectional survey to describe medicine use among Syrian asylum seekers and refugees in a German federal state: looking beyond infectious diseases. BMJ Open. 2021 09 28; 11(9):e053044. PMID: 34588262; PMCID: PMC8479972; DOI: 10.1136/bmjopen-2021-053044;
Seiglie JA, Serván-Mori E, Manne-Goehler J, Meigs JB, Miranda JJ, Sosa-Rubí SG, Silverman-Retana O, Wexler DJ, Wirtz VJ. Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study. Diabetes Res Clin Pract. 2021 Aug; 178:108953. PMID: 34298043; PMCID: PMC8331361; DOI: 10.1016/j.diabres.2021.108953;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
2019 International Society in Pharmacoepidemiology and Drug Safety (ISPE):
2017-2019 International Society in Pharmacoepidemiology and Drug Safety (ISPE):
Chair, Special Interest Group in Drug Utilization
2015 Boston University School of Public Health:
Boston University School of Public Health: Excellence in Teaching Award
2014-2016 The Lancet Commission on Essential Medicines Policies:
2009-2014 National System of Researchers (SNI), National Council for Science and Technology, Mexico :
2009-2010 Coordinating Commission of the National Institutes of Health and Tertiary Hospitals, Mexico:
Excellence in Research Productivity
2007 Research Conference of the National Institutes of Health and Tertiary Hospitals, Mexico:
Nominee for Best Research Presentation
2007-2009 National System of Researchers (SNI), National Council for Science and Technology, Mexico:
Awarded Membership as Candidate
1999-2003 School of Pharmacy, University of London:
PhD Studies Scholarship
Available to Mentor as: (Review Mentor Role Definitions)
I am committed to mentoring. Throughout my career I have been mentoring MPH, DrPH and PhD students as well as peer faculty. I believe that mentoring and sponsorship are critical for career development.
My experience has been that there is a significant reciprocity when mentoring. I have enjoyed learning with and from the many mentees over my entire career. I think that good mentorship depends on the willingness and capability of both parties (mentor and mentee) to ask questions, challenge assumptions and introduce new ideas and perspectives.
I am the founding faculty of the Emerging Women Leaders Program, a career mentorship program for DrPH and PhD students at Boston University School of Public Health.
Co-Mentor or Peer Mentor
Research / Scholarly Mentor